Thursday, Feb 27 2020 | Time 17:39 Hrs(IST)
image
  • Police's inaction, politics of hate reasons for Delhi violence, alleges Tarigami
  • Aurangabad BJP urges Police not to grant permission for AIMIM meet
  • Govt to set up Science and Tech committee to enhance students's interest: Vij
  • Police constable suspended for kicking suicide victim’s father
  • Day chill revisits Kashmir; Rain, snow predicted from Friday
  • Inclusive sanitation as part of urban agenda can’t be ignored to achieve 5 trillion dollars economy: Puri
  • Govt shops accused of selling liquor to selected companies without permits
  • Number of COVID-19 cases in Switzerland reaches four
  • Confer Auroville ‘University of Peace’ status: Prof Swaminathan
  • Well settled process followed in Justice Muralidhar's transfer: Law minister
  • Army Commander presents bravery awards to soldiers at Investiture Ceremony
  • Aravali Hills: Selja writes letter to Haryana CM
  • SIAM proposes to set up South Asian Automotive Forum
  • Sixth Coast Guard OPV 'Yard 45006' launched
  • Delhi violence: Board exam postponed for Feb 28, 29
Business Economy


Morepen Lab’s net profit rises by 179 pc

New Delhi, May 1 (UNI) Morepen Laboratories Limited has reported a 179 per cent rise in its net profit at Rs 7.73-crore and 17.4 per cent rise in its net sales revenue at Rs 141-crore in the fourth quarter (Q4) of fiscal 2016-17.

The net profit and the net sales revenue stood at Rs 2.77-crore and Rs 119.77-crore in the corresponding quarter of the fiscal 2015-16.

Announcing the results, Sushil Suri, Chairman and Managing Director, Morepen Laboratories, said that the company’s expanding global reach assisted in achieving a higher topline in Q4 FY 2016-17. Export sales registered a growth of 29 per cent in Q4 at Rs 73-crore. Sales from domestic operations, however, registered a marginal growth of 7 per cent at Rs 68-crore.

“The bulk drugs (API) segment continued to excel in the quarter by contributing 67 per cent to the company’s total turnover. Morepen Lab’s blockbuster bulk drug Loratadine has once again emerged as a growth accelerator for the company in Q4 FY 2016-17,” he said.

According to Mr Suri, Sales from Loratadine alone increased by 54 per cent in Q4 at Rs 34.35-crore. Total bulk drugs sales in Q4 increased by 21 per cent at Rs 94.35-crore.

OTC (Over the Counter) products and Formulations also recorded good sales numbers for the quarter under consideration. Total sales from OTC products, comprising Burnol & Lemolate, went up by 11 per cent in Q4 FY 2016-17.

“Consistent focus on backward integration, research and process innovation has helped company garner better foothold in the market and company’s vision to invest in the new markets is showing results on the expected lines,” he said.

During the entire financial year 2016-17, Morepen Lab’s net profit grew by 46 per cent at Rs 23.04-crore as against Rs 15.78-crore net profit registered in the previous fiscal. Net sales revenue in FY 2016-17 grew by 21 per cent at Rs 529.18-crore.

The total API business registered a growth of 23 per cent at Rs 340.13-crore, Dr. Morepen Home Diagnostics business registered a growth of 23 per cent at Rs 77.76-crore, formulations business registered a growth of 10 per cent at Rs 26.59-crore and Product Contract Manufacturing and Brand Sharing business grew by 16 per cent at Rs 84.69-crore.
UNI ADP RSA SNU 1539
More News

Rupee ends up by 10 paise against USD

27 Feb 2020 | 5:15 PM

Mumbai, Feb 27 (UNI) The Rupee on Thursday gained ten paise to 71.57 on selling of US Dollars by bankers and importers, dealers at Forex Market said.

see more..

Honda launches Unicorn BSVI

27 Feb 2020 | 5:13 PM

New Delhi, Feb 27 (UNI) Honda Motorcycle & Scooter India Pvt. Ltd. on Thursday introduced new Unicorn BSVI starting at Rs. 93,593, a statement here said.

see more..

SIAM proposes to set up South Asian Automotive Forum

27 Feb 2020 | 5:06 PM

New Delhi, Feb 27 (UNI) Society of Indian Automobile Manufacturers (SIAM) proposed to set up a South Asian Automotive Forum, with participation of industry associations and Government representatives from Bangladesh, India, Myanmar, Nepal and Sri Lanka, a statement said here on Thursday.

see more..

Sensex down 143 30 pts

27 Feb 2020 | 5:02 PM

Mumbai, Feb 27 (UNI) Extending losses for the fifth straight session, the BSE Sensex on Thursday slipped by 143.30 points to settle at 39,745.66 as heavy selling was witnessed in Energy, IT, Realty, Power and Oil and Gas stocks.

see more..

Conference of K'taka State Federation of Petroleum dealers to be held on Feb 29

27 Feb 2020 | 4:55 PM

Udupi, Feb 27 (UNI) Karnataka State Federation of Petroleum Dealers will organise a state-level conference on February 29 and March 1 here.

see more..
image